A mission that matters. Guiding the development of molecules from clinical trials to commercialization, advancing the aseptic manufacturing of branded and generic inhalation and ophthalmic medications, and compounding unit dose syringes have one thing in common – no margin for error. Ritedose rigorously controls its supply chain, systems, processes and outcomes to produce pharmaceutical products that provide maximum risk mitigation and the safest delivery system possible. Our work is done in deference not only to patients, but to the people who care for them. Our passion for this endeavor is 8 billion doses strong. Our journey. Founded in 1995 in Columbia, S.C., The Ritedose Corporation is an industry leader in pharmaceutical development, aseptic cGMP manufacturing and 503B outsourcing solutions, and has mastered blow-fill-seal (BFS) technology to ensure sterile, efficient, consistent and safe unit dose delivery. Ritedose customers range from small startups and large pharmaceutical companies to wholesalers, retail pharmacies and hospital systems; 99% are U.S. companies. Our highly touted, 25-year track record includes delivery of more than 8 billion doses since 2012 without a single interruption and an exceptional inspection history and compliance record as noted by regulators, including the U.S. Food & Drug Administration, multiple state Boards of Pharmacy, U.S. Pharmacopeia and the National Association of Boards of Pharmacy. Facilities that support 2+ billion units a year. Ritedose conducts all its development, manufacturing and packaging on a 33-acre campus in South Carolina. With more than 400 employees occupying 273,000 square feet – a 120,000-square-foot manufacturing facility adjacent to a 153,000-square-foot packaging and distribution facility – our annual capacity is 2+ billion units. Through a $7 million investment in 2018, we expanded operations and added the Ritedose Outsourcing Facility. This 503B facility manufactures and delivers sterile, pre-filled syringe products for hospitals and healthcare facilities throughout the U.S., focusing on drugs that are medically necessary and in short supply nationally. They are our why. Ours is a culture rooted in honoring the patient. In every product we develop, every process we improve, every drug we manufacture, we see patients and those who deliver their care. It’s why we have exacting standards and an eagerness to make everything right. An invested community partner. Ritedose is dedicated to the community we call home. We provide financial support and volunteers to local organizations like Homeless No More, Epworth Children’s Home, Ronald McDonald House, Harvest Hope Food Bank and more. As Columbia and the nation have grappled with the COVID-19 pandemic, Ritedose has worked to uphold our team and support those in the community impacted by the public health and economic crises. Here’s how: Supplied 1,500 bottles of hand sanitizer to local hospitals and front-line workers Deployed three 3D printers operating 24/7 to make more than 65,000 ear-savers, then donated them to front-line healthcare workers to use with masks Provided special compensation to employees to address economic challenges Leadership Jody Chastain Chief Executive Officer Steven Franchak Chief Financial Officer Shawn Miller Chief Information Officer Uday Doshi VP of Scientific Affairs Mohammad Sadeghi VP of Quality Angie Koen VP of Technical Services Shawn Collins VP of Operations Lori Wedemyer Director of HR Carol Morgan Business Development Milestones 2000 TRC receives FDA approval to manufacture & distribute drug products 2003 TRC obtains first ANDA Pioneers in aseptic production of sterile, single-dose medication CONTACT US Copyright © 2021 The Ritedose Corporation. All rights reserved.